HEI · Coteau

HEI

HEICO Corporation

$305.21

-0.96% 2026-10-20

Industrials

1M 3M 6M 1Y 2Y

HEISPY

+2.9%

+2.3%

-10.3%

+10.6%

YTD

-5.6%

-2.4%

Live chart

Loading live chart…

Grades vs sector

Momentum

Not enough data yet

–

Percentile within its GICS sector across the S&P 1500.

Growth

Not enough data yet

–

Percentile within its GICS sector across the S&P 1500.

Value

Not enough data yet

–

Percentile within its GICS sector across the S&P 1500.

Profitability

Not enough data yet

–

Percentile within its GICS sector across the S&P 1500.

Revisions

Not enough data yet

–

30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Our models

Not held by any of our 5 live models right now.

Quality Growth

not ranked (outside this model's universe or screens)

Momentum Top 15

not ranked (outside this model's universe or screens)

Momentum Blend

not in the current book

New Highs Growth

not ranked (outside this model's universe or screens)

Conviction 20

not in the current book

News

More news

HEICO (HEI) Could Be 21% Below Fair Value As Gains Revive Valuation Debate

Simply Wall St. · Oct 17

HEICO (HEI) Stock Looks Fully Priced On Its 122% Five Year Run

Simply Wall St. · Oct 17

Does Heico (HEI) Have the Potential to Rally 26.83% as Wall Street Analysts Expect?

Zacks · Oct 16

Morgan Stanley Adjusts Price Target on HEICO to $345 From $365

MT Newswires · Oct 16

Zacks Investment Ideas feature highlights: CoreWeave, Cinemark, Oscar Health and Heico

Zacks · Oct 16

Key stats

Market cap$42.7B

P/E (trailing)50.9

P/E (forward)42.2

52-week range256.11 – 376.86

Revenue growth (YoY, latest qtr)+23.1%

Dividend yield0.08%

Analyst consensusBuy (20)

Mean price target$390.70 (+28%)

Valuation and fundamentals

Valuation & fundamentals

Bottom line

Looks undervalued

Model read-out from the numbers below, not advice. Score +4 (DCF counts double).

▲DCF (base case)above the price by 15%

▲Piotroski F-score7/9

▲Altman Z7.7 (safe)

▲Net debt / EBITDA-0.2x

▲Analyst target+28% (20 analysts)

Discounted cash flow

Bear

$174

-43%

growth 15% · disc. 10.7% · term. 2.0%

Base

$353

+15%

growth 25% · disc. 9.7% · term. 2.5%

Bull

$620

+103%

growth 31% · disc. 8.7% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal

Today's price assumes free cash flow grows about 17% a year for 10 years.

Implied

+17%/yr

FCF, last 3 yrs

+25%/yr

FCF, last 5 yrs

+17%/yr

Revenue, last 3 yrs

+27%/yr

Revenue, last 5 yrs

+20%/yr

Same inputs as the DCF above: trailing free cash flow 1.0B, 9.7% discount rate, 2.5% growth after year 10, net cash and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.

Edit assumptions · recalculates instantly

Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-07-31). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.09 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs sector

Forward EPS $7.23 vs trailing $6.00 (+20% expected growth). Forward P/E uses analysts' next-12-month estimate.

Quality & financial health

Gross margin

40.4%

Operating margin

24.0%

FCF margin

19.9%

Net margin

16.4%

Return on equity

17.1%

Return on invested capital

21.6%

Net debt / EBITDA

-0.2×

Current ratio

2.7×

Interest cover

9.4×

Cash conversion (OCF/NI)

1.3×

Piotroski F-score 7/9 · last two fiscal years

✓ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✓ No share dilution✗ Gross margin improved✓ Asset turnover improved

Altman Z-score 7.7 (safe zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.

Analysts

Mean target

$391

+28%

Analysts

Buy

Range

$294–$491

low – high

● price · ◆ mean target

Annual history

FY	Revenue	Net income	Free cash flow
2025	$4.5B	$690.4M	$861.4M
2024	$3.9B	$514.1M	$614.1M
2023	$3.0B	$403.6M	$399.3M
2022	$2.2B	$351.7M	$435.9M
2021	$1.9B	$304.2M	$407.9M
2020	$1.8B	$314.0M	$386.2M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +26.6%.

Earnings

Next report: 2026-12-17 · during market · EPS est 1.64

EstimateActual (beat)Actual (miss)

Report	EPS est	Actual	Surprise
2026-08-25	1.51	1.67	+10.6%
2026-05-27	1.34	1.66	+24.2%
2026-02-25	1.29	1.35	+4.7%
2025-12-18	1.22	1.33	+9.3%
2025-08-25	1.14	1.26	+10.8%
2025-05-27	1.03	1.12	+8.3%
2025-02-26	0.95	1.20	+26.1%
2024-12-17	0.98	0.99	+1.1%

Quarterly revenue

Quarter	Revenue	YoY
2026-07-31	$1.4B	+23.1%
2026-04-30	$1.4B	–
2026-01-31	$1.2B	–
2025-10-31	$1.2B	–
2025-07-31	$1.1B	–

Analyst actions

Morgan Stanley

2026-10-19 · main

Equal-Weight → Equal-Weight
PT $345

TD Cowen

2026-10-09 · main

Hold → Hold
PT $330

Wells Fargo

2026-09-30 · main

Equal-Weight → Equal-Weight
PT $335

Guggenheim

2026-09-15 · init

→ Neutral

Morgan Stanley

2026-09-02 · main

Equal-Weight → Equal-Weight
PT $365

Citigroup

2026-08-28 · main

Buy → Buy
PT $441

Recent dividends

2026-07-01: $0.130 · 2026-01-05: $0.120 · 2025-07-01: $0.120 · 2025-01-03: $0.110 · 2024-07-01: $0.110 · 2024-01-03: $0.100 · 2023-06-30: $0.100 · 2023-01-04: $0.100

Stats refreshed 2026-10-20 18:13:52 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

coteau

Coteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.

How it works Disclaimer Terms Privacy Data status